Chimeric Therapeutics Competitors and Similar CompaniesClear all

Chimeric Therapeutics's competitors and similar companies include Spur Therapeutics and Codiak Biosciences.

	Chimeric Therapeutics Chimeric Therapeutics is a clinical-stage cell therapy company.	Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.	Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Founding Date	Founding Date 2020	Founding Date 2015	Founding Date 2015
Type	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech therapy	Tags Healthcare biotech therapy	Tags Healthcare biotech therapy
Locations	Locations Carlton, AU HQ	Locations Stevenage, GB HQ Boston, US New York, US	Locations Cambridge, US HQ
Employees	Employees N/A	Employees 122	Employees 992% decrease
Valuation ($)	Valuation ($) 8.6 m	Valuation ($) N/A	Valuation ($) 2.8 m
Financial
Revenue (est.)	Revenue (est.) $4m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $22.9m (FY, 2021)
Cost of goods	Cost of goods $847k (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $11.7m (FY, 2025)	Gross profit $8.9m (FY, 2022)	Gross profit N/A
Net income	Net income ($10.4m) (FY, 2025)	Net income ($89m) (FY, 2022)	Net income ($37.2m) (FY, 2021)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 289.3m	Total funding raised $ 168.5m